In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer cases

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Panghal, Manju ^a   Kaushal, Vivek ^b   Yadav, Jaya P ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b PT B D SHARMA UNIVERSITY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APHODELUS TENUIFOLIUS EXTRACT; ASPARAGUS RACEMOSUS EXTRACT; BALANITES AEGYPTIACA EXTRACT; CESTRUM DIURNUM EXTRACT; CORDIA DICHOTOMA EXTRACT; ECLIPTA ALBA EXTRACT; MURRAYA KOENIGII EXTRACT; PEDALIUM MUREX EXTRACT; PLANT EXTRACT; RICINUS COMMUNIS EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPARAGUS RACEMOSUS; ASPERGILLUS FUMIGATUS; ASPHODELUS TENUIFOLIUS; BACTERIUM ISOLATE; BALANITES AEGYPTIACA; BLOOD CULTURE; BROTH DILUTION; CANCER PATIENT; CANDIDA ALBICANS; CESTRUM DIURNUM; CORDIA DICHOTOMA; DISK DIFFUSION; ECLIPTA ALBA; ESCHERICHIA COLI; FENUGREEK; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; KLEBSIELLA PNEUMONIAE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MOUTH CANCER; MURRAYA KOENIGII; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PEDALIUM MUREX; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RICINUS COMMUNIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; DRUG EFFECT; FUNGUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH TUMOR; MYCOSIS;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH NEOPLASMS; MYCOSES; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 79956197893     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-21     Document Type: Article

References (68)

1. Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clinical Infectious Diseases 2004, 39(Suppl 1):S32--7.
2. Klastersky J, Paesmans M, Rubenstein E. The MASCC Risk Index: a multinational scoring system to predict low-risk febrile neutropenic cancer patients. Journal Clinical Oncology 2000, 18:3038-51.
3. Rolston KVI. Challenges in the treatment of infections caused by gram-positive and gram- negative bacteria in patients with cancer and neutropenia. Clinical Infectious Diseases 2005, 40:S246-S252. 10.1086/427331, 15768330.
4. Akova M. Emerging problem pathogens: A review of resistance patterns over time. International Journal of Infectious Diseases 2006, 10(S2):S3-S8.
5. Hughes WT, Armstrong D, Bodey GP. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 2002, 34:730-51. 10.1086/339215, 11850858.
6. Rolston KV, Jones RN, Coyle EA, Prince RA. Emergence of quinolone resistant Escherichia coli at a cancer center [abstract]. 2007, 506. 45th Annual Meeting of the Infectious Diseases Society of America (IDSA), San Diego, CA.
7. Gomez L, Garau J, Estrada C, Marquez M, Dalmau D, Xercavins M, Marti JM, Estany C. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin- resistant Escherichia coli. Cancer 2003, 97:419-424. 10.1002/cncr.11044, 12518366.
8. Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. Journal of Antimicrobial Chemotherapy 2008, 61:721-728. 10.1093/jac/dkm514, 18218645.
9. Toleman MA, Rolston K, Jones RN, Walsh TR. Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d', ß-lactamase in Pseudomonas aeruginosa. Antimicrobial Agents Chemotherapy 2003, 47:2859-2863.
10. Ohmagari N, Hanna H, Graviss L. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005, 104:205-212. 10.1002/cncr.21115, 15880433.
11. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clinical Infectious Diseases 2007, 45:1602-1609. 2007, 10.1086/522998, 18190323.
12. Green M, Wald ER. Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting. Annals of Allergy, Asthma and Immunology 1996, 77:167-173.
13. Williams JD, Sefton AM. The prevention of antibiotic resistance during treatment. Infection 1999, 2:29-31.
14. Rice LB. Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antibiotics. Pharmacotherapy 1999, 19:120-128.
15. Khan R, Islam B, Akram M, Shakil S, Ahmad A, Ali SM, Siddiqui M, Khan AU. Antimicrobial activity of five herbal extracts against Multi Drug Resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules 2009, 14:586-597. 10.3390/molecules14020586, 19214149.
16. Robbers J, Speedie M, Tyler V. Pharmacognosy and pharmacobiotechnology. 1996, Williams and Wilkins, Baltimore.
17. Daciana I, Bara II. Plant products as antimicrobial agents. Analele Stiinţifice ale Universitaţii Alexandru Ioan Cuza Secţiunea Genetica si Biologie Moleculara 2007, VIII. TOM.
18. Paxton JD. Phytoalexins a working redefinition. Phytopathology 1980, 132:1-45.
19. VanEtten HD, Mansfield JW, Bailey J, Farmer EE. Letter to the editor: two classes of plant antibiotics: phytoalexins versus phytoanticipins. Plant Cell 1994, 6:1191-1192. 160512, 12244269.
20. Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008, 15:639-652. 10.1016/j.phymed.2008.06.008, 18599280.
21. Chopra RN. Indigenous Drugs of India. 1958, Dhur and Sons Private Limited., Calcutta, 2, Revised and Enlarged by Chopra R N, Chopra, IC, Handa KL and Kapur LD.
22. Kirtikar KR, Basu BD. Indian medicinal plants. 1968, I. Allhabad, India: Lalit Mohan Basu publisher and distributor.
23. Nadkarani KM. Indian Material Medica. 1982, II. Mumbai: Popular Prakashan private limited.
24. Satavat GV, Gupta AK. Medicinal plants of India. 1987, II. New Delhi: ICMR.
25. Nadkarani KM. Indian Material Medica. 1989, III. Mumbai: Popular Prakashan Private Limited.
26. Chopra RN, Nayer SI, Chopra IC. Glossary of Indian medicinal plants. 1992, 7-246. New Delhi: Council of scientific and Industrial Research, 3.
27. Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. Journal of Ethnopharmacology 1998, 62:183-193. 10.1016/S0378-8741(98)00055-5, 9741890.
28. Rautemaa R, Rusanen P, Richardson M, Meurma JH. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. Journal of Medical Microbiology 2006, 55:1447-1451. 10.1099/jmm.0.46615-0, 17005796.
29. Shimeld LA. Essential of Diagnostic Microbiology. 1998, International Thomas Publishing Company, USA.
30. Hawkey P, Law D. Medical Bacteriology. 2004, Oxford University Press, New York, 2.
31. Ryan KJ. Normal Microbial flora. Medical Microbiology 2004, McGraw Hill, USA, Sherris JC, Ryan KJ, Ray GC, Fourth.
32. Mukherjee KL. A procedure manual for routine diagnostic test. 2006, II. Grew Hill publishing compd. Limited, Tata Mac.
33. Bhandari MM. Flora of the Indian Desert. 1990, Scientific Publishers, Jodhapur.
34. Kumar S. Flora of Haryana. 2001, Publishers Bishen S, Mahendra PS, New Delhi.
35. Sharma N. The Flora of Rajasthan. 2002, 280. Aavishkar Publishers, Jaipur.
36. Sharma NK. Ethno-medico-Religious plants of Hadoti plateau (S. E. Rajasthan)-a preliminary survey. Ethnobotany. 2002, Aaviskar Publishers, Jaipur, Trivedi PC.
37. Bauer AW, Kirby WMM, Sheriss JC, Turc M. Antibiotic susceptibility testing by standardized single method. American Journal of Clinical Pathology 1996, 45:493-496.
38. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 2007, 42:321-324. 10.1016/j.ymeth.2007.01.006, 1895922, 17560319.
39. Harborn JB. Phytochemical Methods, A guide to modern Techniques of plant analysis. 1988, London: Chapman and Hall Limited.
40. Kokate CK. Practical pharmacognosy. 2005, 107. Published by Jain MK for Vallabh Prakashan, Pitampura, New Delhi.
41. Bonjar GHS. Approaches in screening for antibacterial in plants. Asian Journal of Plant sciences 2004, 31(1):55-60.
42. Kenneth VIR. New antimicrobial agents for the treatment of bacterial infections in cancer patients. Hematological Oncology 2009, 27:107-114. 10.1002/hon.898, 19569253.
43. Schultes RE. Tapping our heritage of ethnobotanical lore. Economic Botany 1960, 14:257-262.
44. Valsaraj R, Pushpangadan P, Smitt UW, Adsersen A, Nyman U. Antimicrobial screening of selected medicinal plants from India. Journal of Ethnopharmacology 1997, 58:75-83. 10.1016/S0378-8741(97)00085-8, 9406894.
45. Khafagy SM, Ishrak K. Screening culture of some Sinani medicinal plants for their antibiotic activity. Egyptian Journal of Microbiology 1999, 34(4):613-627.
46. Mandal SC, Nandy A, Pal M, Saha BP. Evaluation of Antibacterial activity of Asparagus racemosus willd. Root. Phytotherapy Research 2000, 14:118-119. 10.1002/(SICI)1099-1573(200003)14:2<118::AID-PTR493>3.0.CO;2-P, 10685109.
47. Swarnkar S, Katewa SS. Antimicrobial activities of some tuberous medicinal plants from aravalli hills of Rajasthan. Journal of Herbal Medicine and Toxicology 2009, 3(1):53-58.
48. Uma B, Prabhakar K, Rajendra S. Anticandidal activity of Asparagus racemosus. Indian Journal of Pharmaceutical Sciences 2009, 71(3):342-343. 2009, 10.4103/0250-474X.56017, 2865803, 20490311.
49. Girish HV, Satish S. Antibacterial Activity of Important Medicinal Plants on Human Pathogenic Bacteria-a Comparative Analysis. World Applied Sciences Journal 2008, 5(3):267-271.
50. Felix MT. Medical Microbiology. 1982, Churchill Livingstone (Publishers): London, UK.
51. Eloff JN. Which extractant should be used for the screening of antimicrobials components from plants?. Journal of Ethnopharmacology 1998, 60:1-8. 10.1016/S0378-8741(97)00123-2, 9533426.
52. Nimri LF, Meqdam MM, Alkofahi A. Antibacterial activity of Jordanian medicinal plants. Pharmaceutical Biology 1999, 37(3):196-201.
53. Iinuma M, Tsuchiya H, Sato M, Yokoyama J, Ohyama M, Ohkawa Y, Tanaka T, Fujiwara S, Fujii T. Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Journal of Pharmaceutical Pharmacology 1994, 46:892-895. 1994.
54. Kim H, Park SW, Park JM, Moon KH, Lee CK. Screening and isolation of antibiotic resistant inhibitors from herb materials I -- Resistant Inhibition of 21 Korean Plants. Natural Product Science 1995, 1:50-54.
55. Ahmed AA, Mahmoud AA, Williams HJ, Scott AI, Reibenspies JH, Mabry TJ. New sesquiterpene a-methylene lactones from the Egyptian plant Jasonia candicans. Journal Natural Products 1993, 56:1276-1280.
56. Batista O, Duarte A, Nascimento J, Simones MF. Structure and antimicrobial activity of diterpenes from the roots of Plectranthus hereroensis. Journal Natural Products 1994, 57:858-861.
57. Tsuchiya H, Sato M, Miyazaki T, Fujiwara S, Tanigaki S, Ohyama M, Tanaka T, Iinuma M. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. Journal of Ethnopharmacology 1996, 50:27-34. 10.1016/0378-8741(96)85514-0, 8778504.
58. Rabe T, Van Stadin VJ. Antibacterial of South African plants used for medicinal purposes. Journal of Ethnopharmacology 1997, 56:81-87. 10.1016/S0378-8741(96)01515-2, 9147258.
59. Barre JT, Bowden BF, Coll JC, Jesus J, Fuente VE, Janairo GC, Ragasa CY. A bioactive triterpene from Lantana camara. Phytochemistry 1997, 45:321-324. 10.1016/S0031-9422(96)00805-9, 9162177.
60. Amaral JA, Ekins A, Richards SR, Knowles R. Effect of selected monoterpenes on methane oxidation, denitrification, and aerobic metabolism by bacteria in pure culture. Applied Environmental Microbiology 1998, 64:520-525.
61. Cowan CC. Plant Products as Antimicrobial Agents. Clinical Microbiology Review 1999, 12(4):564-582.
62. Santhi R, Alagesaboopathi C, Pandian MR. Antibacterial activity of Andrographis lineata Nees and Andrographis echioides Nees of Shevaroy hills of Salem District, Tamil Naidu. Advance concepts in Plant Sciences 2006, 19(II):371-375.
63. Mohanasundari C, Natarajan D, Srinivasan K, Umamaheswari SA, Ramachandran A. Antibacterial properties of Passiflora foetida L. -a common exotic medicinal plant. African Journal Biotechnology 2007, 6(23):2650-2653.
64. Britto JS. Comparative antibacterial activity study of Solanum incanum L. Journal Swamy Botany Club 2001, 18:81-82.
65. Krishna KT, Ranjini CE, Sasidharan VK. Antibacterial and antifungal activity of secondary metabolites from some medicinal and other common plant species. Journal Life Sciences 1997, 2:14-19.
66. Singh I, Singh VP. Antifungal properties of aqueous and organic solution extracts of seed plants against Aspergillus flavus and A. niger. Phytomorphol 2000, 50:151-157. 2000.
67. Natarajan E, Senthilkumar S, Xavier FT, Kalaiselvi V. Antibacterial activities of leaf extracts of Alangium salviifolium. Journal Tropical Medicinal Plants 2003, 4:9-13.
68. Natarajan D, Britto JS, Srinivasan K, Nagamurugan N, Mohanasundari C, Perumal G. Anti-bacterial activity of Euphorbia fusiformis- a rare medicinal herb. Journal of Ethnopharmacology 2005, 102:123-126. 10.1016/j.jep.2005.04.023, 16159702.